Yash Optics & Lens Share Price
Sector: Medical Equipment & Supplies
82.00 +0.75 (0.92%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
78.00
Today’s High
82.00
52 Week Low
72.60
52 Week High
121.85
Key Metrics
- Market Cap (In Cr) 203.08
- Beta -
- Div. Yield (%) 0
- P/B 6.78
- TTM P/E 23.5
- Sector P/E 24.94
- D/E 0
Yash Optics & Lens Analysis
Price Analysis
-
1 Week1.68%
-
3 Months4.01%
-
6 Month-4.22%
-
YTD-6.15%
-
1 Year-9.28%
Yash Optics & Lens News
Upcoming IPOs: 3 SME public issues and 6 new listings scheduled for Dalal Street
3 min read . 07 Apr 2024Upcoming IPOs: One new public issue and 10 listings scheduled for this week
7 min read . 31 Mar 2024Yash Optics & Lens IPO subscribed over 8 times so far on last day
2 min read . 03 Apr 2024Yash Optics & Lens Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 41.11
- Selling/ General/ Admin Expenses Total
- 12.48
- Depreciation/ Amortization
- 0.87
- Other Operating Expenses Total
- 0.17
- Total Operating Expense
- 27.35
- Operating Income
- 13.76
- Net Income Before Taxes
- 12.12
- Net Income
- 9.02
- Diluted Normalized EPS
- 3.64
- Period
- 2024
- Total Assets
- 60.57
- Total Liabilities
- 30.74
- Total Equity
- 29.84
- Tangible Book Valueper Share Common Eq
- 12.05
- Period
- 2024
- Cashfrom Operating Activities
- 2.97
- Cashfrom Investing Activities
- -18.73
- Cashfrom Financing Activities
- 33.39
- Net Changein Cash
- 17.63
- Period
- 2023
- Total Revenue
- 39.69
- Selling/ General/ Admin Expenses Total
- 12.11
- Depreciation/ Amortization
- 0.7
- Other Operating Expenses Total
- 0.14
- Total Operating Expense
- 27.88
- Operating Income
- 11.81
- Net Income Before Taxes
- 10.85
- Net Income
- 8.07
- Diluted Normalized EPS
- 3.26
- Period
- 2023
- Total Assets
- 34.05
- Total Liabilities
- 15
- Total Equity
- 19.05
- Tangible Book Valueper Share Common Eq
- 7.69
- Period
- 2023
- Cashfrom Operating Activities
- -12.14
- Cashfrom Investing Activities
- -8.35
- Cashfrom Financing Activities
- 9.85
- Net Changein Cash
- -10.65
- Period
- 2022
- Total Revenue
- 29.75
- Selling/ General/ Admin Expenses Total
- 8.56
- Depreciation/ Amortization
- 0.61
- Other Operating Expenses Total
- 0.09
- Total Operating Expense
- 20.14
- Operating Income
- 9.61
- Net Income Before Taxes
- 9.16
- Net Income
- 6.82
- Diluted Normalized EPS
- 2.75
- Period
- 2022
- Total Assets
- 24.45
- Total Liabilities
- 13.4
- Total Equity
- 11.05
- Tangible Book Valueper Share Common Eq
- 4.42
- Period
- 2022
- Cashfrom Operating Activities
- 7.72
- Cashfrom Investing Activities
- -4.88
- Cashfrom Financing Activities
- -2.5
- Net Changein Cash
- 0.34
- Period
- 2021
- Total Revenue
- 14.96
- Selling/ General/ Admin Expenses Total
- 2.58
- Depreciation/ Amortization
- 0.08
- Other Operating Expenses Total
- 0.05
- Total Operating Expense
- 12.99
- Operating Income
- 1.97
- Net Income Before Taxes
- 1.49
- Net Income
- 1.06
- Diluted Normalized EPS
- 0.43
- Period
- 2021
- Total Assets
- 12.15
- Total Liabilities
- 7.89
- Total Equity
- 4.27
- Tangible Book Valueper Share Common Eq
- 1.72
- Period
- 2021
- Cashfrom Operating Activities
- -0.05
- Cashfrom Investing Activities
- -0.04
- Cashfrom Financing Activities
- 0.46
- Net Changein Cash
- 0.36
- Period
- 2024-09-30
- Total Revenue
- 19.5
- Selling/ General/ Admin Expenses Total
- 3.94
- Depreciation/ Amortization
- 0.48
- Other Operating Expenses Total
- 4.25
- Total Operating Expense
- 14.06
- Operating Income
- 5.45
- Net Income Before Taxes
- 6.2
- Net Income
- 4.55
- Diluted Normalized EPS
- 1.85
- Period
- 2024-09-30
- Total Assets
- 108.12
- Total Liabilities
- 22.78
- Total Equity
- 85.34
- Tangible Book Valueper Share Common Eq
- 34.46
- Period
- 2024-09-30
- Cashfrom Operating Activities
- -0.71
- Cashfrom Investing Activities
- -8.35
- Cashfrom Financing Activities
- 41.87
- Net Changein Cash
- 32.81
- Period
- 2024-03-31
- Total Revenue
- 41.11
- Selling/ General/ Admin Expenses Total
- 12.48
- Depreciation/ Amortization
- 0.87
- Other Operating Expenses Total
- 0.17
- Total Operating Expense
- 27.35
- Operating Income
- 13.76
- Net Income Before Taxes
- 12.12
- Net Income
- 9.02
- Diluted Normalized EPS
- 3.64
- Period
- 2024-03-31
- Total Assets
- 60.57
- Total Liabilities
- 30.74
- Total Equity
- 29.84
- Tangible Book Valueper Share Common Eq
- 12.05
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 2.97
- Cashfrom Investing Activities
- -18.73
- Cashfrom Financing Activities
- 33.39
- Net Changein Cash
- 17.63
- Period
- 2023-09-30
- Total Revenue
- 18.66
- Selling/ General/ Admin Expenses Total
- 5.54
- Depreciation/ Amortization
- 0.41
- Other Operating Expenses Total
- 0.06
- Total Operating Expense
- 12.13
- Operating Income
- 6.53
- Net Income Before Taxes
- 5.76
- Net Income
- 4.23
- Diluted Normalized EPS
- 1.71
- Period
- 2023-09-30
- Total Assets
- 54.13
- Total Liabilities
- 30.79
- Total Equity
- 23.34
- Tangible Book Valueper Share Common Eq
- 9.39
- Period
- 2023-09-30
- Cashfrom Operating Activities
- 4.72
- Cashfrom Investing Activities
- -17.37
- Cashfrom Financing Activities
- 12.79
- Net Changein Cash
- 0.13
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Yash Optics & Lens Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Mallcom (india)
- 1130
- -9.4
- -0.82
- 1780
- 937.2
- 703.52
- Nureca
- 255.9
- 5
- 1.99
- 447
- 198
- 255.9
- Yash Optics & Lens
- 82
- 0.75
- 0.92
- 121.85
- 72.6
- 203.08
- Qms Medical Allied Services
- 88.6
- -3.4
- -3.7
- 153.9
- 72.35
- 158.15
- Mohini Health & Hygiene
- 60
- -1
- -1.64
- 86.9
- 46
- 109.42
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Mallcom (india)
- 18.72
- 2.37
- 19.98
- 9.57
- Nureca
- 302.04
- 1.32
- 9.56
- 10.5
- Yash Optics & Lens
- 22.41
- 6.78
- -
- -
- Qms Medical Allied Services
- 17.58
- 2.02
- 25.22
- 7.64
- Mohini Health & Hygiene
- 10.23
- 1.09
- -
- -
Yash Optics & Lens Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 29-May-25
- Audited Results
- 16-Jan-25
- Others
- 14-Nov-24
- Quarterly Results
- 29-May-24
- Audited Results
- Meeting Date
- Announced on
- Purpose
- 30-Sept-24
- 13-Aug-24
- AGM



